Advertisement

Amphetamines and Other Stimulant Use

  • Curtis L. BaysingerEmail author
Chapter

Abstract

Stimulant abuse, particularly methamphetamine, increased dramatically among women of childbearing age between 1994 and 2006; however, the rate of abuse has plateaued since and use during pregnancy is difficult to estimate. Maternal physiologic effects are similar to that of cocaine, with sympathetic system activation during periods of acute intoxication and significant psychosis with long-term use. Poorer obstetric and neonatal outcomes to include preterm delivery, placental abruption, and small for gestational age deliveries occur; however, long-term child outcomes appear similar to that of non-stimulant-abusing women. Intra- and postpartum obstetric management are similar to that of the cocaine-abusing mother. Neuraxial blockade may be complicated by more frequent and more difficult to treat hypotension due to catecholamine depletion in the chronic non-intoxicated abuser.

Keywords

Addiction Obstetric anesthesia Stimulants MDMA Amphetamine Ecstasy 

References

  1. 1.
    Substance Abuse and Mental Health Services Administration. Results from the 2013 National Survey on Drug Use and Health: summary of national findings. NSDUH series H-48, HHS publication no. (SMA) 14-4863. Rockville: Substance Abuse and Mental Health Services Administration; 2014.Google Scholar
  2. 2.
    Arria AM, Derauf C, Lagasse LL, et al. Methamphetamine and other substance use during pregnancy: preliminary estimates from the Infant Development, Environment, and Lifestyle (IDEAL) study. Matern Child Health J. 2006;10:203–302.CrossRefGoogle Scholar
  3. 3.
    American College of Obstetricians and Gynecologists. Committee opinion number 479: methamphetamine abuse in women of reproductive age. Obstet Gynecol. 2011;117:751–5.CrossRefGoogle Scholar
  4. 4.
    Good MM, Solt I, Acuna JG, et al. Methamphetamine abuse during pregnancy: maternal and neonatal implications. Obstet Gynecol. 2010;116:330–4.CrossRefGoogle Scholar
  5. 5.
    Della Grotta S, LaGasse LL, Arria AM, et al. Patterns of methamphetamine use during pregnancy: results from the Infant Development, Environment, and Lifestyle (IDEAL) study. Matern Child Health J. 2010;14:519–27.CrossRefGoogle Scholar
  6. 6.
    Hyman SE. Addiction to cocaine and amphetamine. Neuron. 1996;16:901–4.CrossRefGoogle Scholar
  7. 7.
    Rayburn WF, Bogenschutz MP. Pharmacotherapy for pregnant women with addictions. Am J Obstet Gynecol. 2004;191:1885–97.CrossRefGoogle Scholar
  8. 8.
    Singer LT, Moore DG, Meeyoung O, et al. One year outcomes of prenatal exposure to MDMA and other recreational drugs. Pediatrics. 2012;130:407–13.CrossRefGoogle Scholar
  9. 9.
    Reynolds EW, Bada HS. Pharmacology of drugs of abuse. Obstet Gynecol Clin North Am. 2003;30:501–22.CrossRefGoogle Scholar
  10. 10.
    Frost EAM, Gist RS, Adriano E. Drugs, alcohol, pregnancy, and the fetal alcohol syndrome. Int Anesthesiol Clin. 2011;49:119–33.CrossRefGoogle Scholar
  11. 11.
    American College of Obstetricians and Gynecologists. ACOG Committee opinion no. 422: at-risk drinking and illicit drug use: ethical issues in obstetric and gynecologic practice. Obstet Gynecol. 2008;112:1449–60.CrossRefGoogle Scholar
  12. 12.
    Smith LM, LaGasse LL, Derauf C, et al. Prenatal methamphetamine use and neonatal neurobehavioral outcome. Neurotoxicol Teratol. 2008;24:17–23.Google Scholar
  13. 13.
    Lu HL, Johnson A, O’Hre ED, et al. Effects of prenatal methamphetamine exposure on verbal memory revealed with functional magnetic resonance imaging. J Dev Behav Pediatr. 2009;30:185–92.CrossRefGoogle Scholar
  14. 14.
    McLafferty LP, Becker M, Dresner N, et al. Guidelines for the management of pregnant women with substance abuse disorders. Psychosomatics. 2016;57:115–30.CrossRefGoogle Scholar
  15. 15.
    D’Apoito K. Breastfeeding and substance abuse. Clin Obstet Gynecol. 2013;56:202–11.CrossRefGoogle Scholar
  16. 16.
    Hanzawa S, Nemoto M, Etoh S, et al. A case of amphetamine-induced down-regulation of the beta-adrenoceptor. Mausi. 2001;50:1242–5.Google Scholar
  17. 17.
    Kuczkowski KM. Anesthetic implications of drug abuse in pregnancy. J Clin Anesth. 2003;15:382–94.CrossRefGoogle Scholar
  18. 18.
    Johnston RR, Way WL, Miller RD. Alteration of anesthetic requirement by amphetamine. Anesthesiology. 1972;36:357–63.CrossRefGoogle Scholar
  19. 19.
    Sullivan JT. Substance abuse and the drug addicted mother. In: Suresh MS, Segal S, Preston RL, Fernando R, Mason CL, editors. Shnider and Levinson’s anesthesia for obstetrics. 5th ed. Baltimore: Wolters Kluwer; 2013. p. 683–98.Google Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of AnesthesiologyVanderbilt University Medical Center, Vanderbilt University HospitalNashvilleUSA

Personalised recommendations